• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.循环神经酰胺和神经鞘磷脂与死亡率的关系:心血管健康研究。
Clin Chem. 2021 Nov 26;67(12):1650-1659. doi: 10.1093/clinchem/hvab182.
2
Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.循环神经酰胺与全因死亡率:“强壮心灵家族研究”。
J Am Heart Assoc. 2024 Jul 2;13(13):e032536. doi: 10.1161/JAHA.123.032536. Epub 2024 Jun 21.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.血浆神经酰胺和神经鞘磷脂与心血管健康研究中的心源性猝死。
JAMA Netw Open. 2023 Nov 1;6(11):e2343854. doi: 10.1001/jamanetworkopen.2023.43854.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.老年人髋关节囊外骨折的手术干预:一项网络荟萃分析。
Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013405. doi: 10.1002/14651858.CD013405.pub2.
7
Cell salvage for the management of postpartum haemorrhage.采用细胞回收技术管理产后出血。
Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD016120. doi: 10.1002/14651858.CD016120.
8
Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.成人哮喘患者使用福莫特罗或沙美特罗常规剂型的安全性:Cochrane系统评价综述
Cochrane Database Syst Rev. 2014 Feb 6;2014(2):CD010314. doi: 10.1002/14651858.CD010314.pub2.
9
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
10
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.

引用本文的文献

1
Increased plasma ceramide levels are associated with arterial stiffness and vascular ageing: a cross-sectional study.血浆神经酰胺水平升高与动脉僵硬度和血管衰老相关:一项横断面研究。
Lipids Health Dis. 2025 Sep 1;24(1):272. doi: 10.1186/s12944-025-02706-3.
2
Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study.循环鞘脂与认知衰退及新发痴呆症的关系:心血管健康研究
Alzheimers Dement (Amst). 2024 Aug 8;16(3):e12623. doi: 10.1002/dad2.12623. eCollection 2024 Jul-Sep.
3
Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease.疾病发病机制中的异常脂质代谢机制。
Int J Mol Sci. 2024 Aug 2;25(15):8465. doi: 10.3390/ijms25158465.
4
Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.循环神经酰胺与全因死亡率:“强壮心灵家族研究”。
J Am Heart Assoc. 2024 Jul 2;13(13):e032536. doi: 10.1161/JAHA.123.032536. Epub 2024 Jun 21.
5
Associations of neighborhood sociodemographic environment with mortality and circulating metabolites among low-income black and white adults living in the southeastern United States.美国东南部生活的贫困黑人和白人成年人的社区社会人口环境与死亡率和循环代谢物的关联。
BMC Med. 2024 Jun 18;22(1):249. doi: 10.1186/s12916-024-03452-6.
6
Circulating sphingolipids and subclinical brain pathology: the cardiovascular health study.循环鞘脂与亚临床脑病理学:心血管健康研究
Front Neurol. 2024 May 3;15:1385623. doi: 10.3389/fneur.2024.1385623. eCollection 2024.
7
Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chinese adults: findings from the Da Qing Diabetes Study.循环棕榈酰神经鞘氨醇水平可预测中国成年人 10 年内心血管疾病死亡的风险增加:来自大庆糖尿病研究的结果。
Cardiovasc Diabetol. 2024 Jan 20;23(1):37. doi: 10.1186/s12933-023-02116-8.
8
Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.血浆神经酰胺和神经鞘磷脂与心血管健康研究中的心源性猝死。
JAMA Netw Open. 2023 Nov 1;6(11):e2343854. doi: 10.1001/jamanetworkopen.2023.43854.
9
Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.血浆代谢组学揭示类鼻疽病的独特生物学和诊断特征。
Am J Respir Crit Care Med. 2024 Feb 1;209(3):288-298. doi: 10.1164/rccm.202207-1349OC.
10
Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications.循环神经酰胺在胰岛素抵抗、糖尿病及其相关并发症中的作用。
Int J Mol Sci. 2023 Sep 13;24(18):14015. doi: 10.3390/ijms241814015.

本文引用的文献

1
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.血浆神经酰胺和基于磷脂的风险评分与急性冠脉综合征后患者心血管死亡风险。
Eur J Prev Cardiol. 2022 May 6;29(6):895-902. doi: 10.1093/eurjpc/zwaa143.
2
Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.血浆神经酰胺和神经鞘磷脂与心房颤动风险的关系:心血管健康研究。
J Am Heart Assoc. 2020 Feb 18;9(4):e012853. doi: 10.1161/JAHA.119.012853. Epub 2020 Feb 5.
3
Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.血浆神经酰胺和神经鞘磷脂与心力衰竭风险的关系。
Circ Heart Fail. 2019 Jul;12(7):e005708. doi: 10.1161/CIRCHEARTFAILURE.118.005708. Epub 2019 Jul 12.
4
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.基于神经酰胺和磷脂的冠心病心血管风险评估评分的开发和验证。
Eur Heart J. 2020 Jan 14;41(3):371-380. doi: 10.1093/eurheartj/ehz387.
5
Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention.大规模血浆脂质组学分析鉴定出可预测二级预防中心血管事件的脂质。
JCI Insight. 2018 Sep 6;3(17). doi: 10.1172/jci.insight.121326.
6
Role of sphingolipids in senescence: implication in aging and age-related diseases.鞘脂类在衰老中的作用:与衰老和与年龄相关疾病的关系。
J Clin Invest. 2018 Jul 2;128(7):2702-2712. doi: 10.1172/JCI97949.
7
Plasma Ceramides.血浆神经酰胺。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.
8
Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients.血浆分子脂质种类浓度可预测冠心病患者的长期临床结局。
J Lipid Res. 2018 Sep;59(9):1729-1737. doi: 10.1194/jlr.P081281. Epub 2018 Jun 1.
9
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.神经酰胺重塑与心血管事件和死亡风险。
J Am Heart Assoc. 2018 May 3;7(10):e007931. doi: 10.1161/JAHA.117.007931.
10
Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study.循环神经酰胺、胰岛素、HOMA-IR 和 HOMA-B:强心家族研究。
Diabetes. 2018 Aug;67(8):1663-1672. doi: 10.2337/db17-1449. Epub 2018 Mar 27.

循环神经酰胺和神经鞘磷脂与死亡率的关系:心血管健康研究。

Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.

机构信息

Department of Epidemiology, University of Washington, Seattle, WA.

Department of Medicine, University of Washington, Seattle, WA.

出版信息

Clin Chem. 2021 Nov 26;67(12):1650-1659. doi: 10.1093/clinchem/hvab182.

DOI:10.1093/clinchem/hvab182
PMID:34580702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8634404/
Abstract

BACKGROUND

Recent studies suggest that associations of ceramides (Cer) and sphingomyelins (SM) with health outcomes differ according to the fatty acid acylated to the sphingoid backbone. The purpose of this study was to assess associations of Cer and SM species with mortality.

METHODS

The study population included participants from the Cardiovascular Health Study (CHS), a community-based cohort of adults aged ≥65 years who were followed from 1992-2015 (n = 4612). Associations of plasma Cer and SM species carrying long-chain (i.e., 16:0) and very-long-chain (i.e., 20:0, 22:0, 24:0) saturated fatty acids with mortality were assessed using Cox proportional hazards models.

RESULTS

During a median follow-up of 10.2 years, 4099 deaths occurred. High concentrations of Cer and SM carrying fatty acid 16:0 were each associated with an increased risk of mortality. Conversely, high concentrations of several ceramide and sphingomyelin species carrying longer fatty acids were each associated with a decreased risk of mortality. The hazard ratios for total mortality per 2-fold difference in each Cer and SM species were: 1.89 (95% CI), 1.65-2.17 for Cer-16, 0.79 (95% CI, 0.70-0.88) for Cer-22, 0.74 (95% CI, 0.65-0.84) for Cer-24, 2.51 (95% CI, 2.01-3.14) for SM-16, 0.68 (95% CI, 0.58-0.79) for SM-20, 0.57 (95% CI, 0.49-0.67) for SM-22, and 0.66 (0.57-0.75) for SM-24. We found no association of Cer-20 with risk of death.

CONCLUSIONS

Associations of Cer and SM with the risk of death differ according to the length of their acylated saturated fatty acid. Future studies are needed to explore mechanisms underlying these relationships.

摘要

背景

最近的研究表明,神经酰胺(Cer)和神经鞘磷脂(SM)与健康结果的关联因酰化到神经鞘氨醇骨架的脂肪酸而异。本研究的目的是评估 Cer 和 SM 物种与死亡率的关联。

方法

研究人群包括来自心血管健康研究(CHS)的参与者,这是一个基于社区的 65 岁以上成年人队列,他们从 1992 年至 2015 年进行了随访(n=4612)。使用 Cox 比例风险模型评估携带长链(即 16:0)和超长链(即 20:0、22:0、24:0)饱和脂肪酸的血浆 Cer 和 SM 物种与死亡率的关联。

结果

在中位随访 10.2 年期间,发生了 4099 例死亡。高浓度的携带脂肪酸 16:0 的 Cer 和 SM 均与死亡率升高相关。相反,携带较长脂肪酸的几种神经酰胺和神经鞘磷脂的高浓度与死亡率降低相关。每种 Cer 和 SM 物种总死亡率每增加 2 倍的风险比为:1.89(95%CI),1.65-2.17 为 Cer-16,0.79(95%CI),0.70-0.88 为 Cer-22,0.74(95%CI),0.65-0.84 为 Cer-24,2.51(95%CI),2.01-3.14 为 SM-16,0.68(95%CI),0.58-0.79 为 SM-20,0.57(95%CI),0.49-0.67 为 SM-22,0.66(0.57-0.75)为 SM-24。我们没有发现 Cer-20 与死亡风险的关联。

结论

Cer 和 SM 与死亡风险的关联因酰化饱和脂肪酸的长度而异。需要进一步研究来探讨这些关系的潜在机制。